Improvement research of Fuzheng Xiaoji Decoctionon tumor growth inhibition and immune function of mice model with lung cancer

ZHAO Lei; LI Hui; PAN Jingren; WANG Danhui; JIANG Qin; XIAO Lu

doi:10.7619/jcmp.20213332

Journal of Clinical Medicine in Practice > 2022 > 26(2): 41-45. > DOI: 10.7619/jcmp.20213332

ZHAO Lei, LI Hui, PAN Jingren, WANG Danhui, JIANG Qin, XIAO Lu. Improvement research of Fuzheng Xiaoji Decoctionon tumor growth inhibition and immune function of mice model with lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 41-45. DOI: 10.7619/jcmp.20213332

Citation:

PDF (1774 KB)

Improvement research of Fuzheng Xiaoji Decoctionon tumor growth inhibition and immune function of mice model with lung cancer

1.
School Infirmary of Xinjiang Medical University, Urumqi, Xinjiang, 830011
2.
Department of Traditional Chinese Medicine, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830028
3.
Department of Traditional Chinese Medicine, Urumqi Maternal and Child Health Care Hospital of the Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, 830000

More Information

Received Date: August 16, 2021
Available Online: January 27, 2022
Published Date: January 27, 2022

Graphical Abstract

Abstract

Abstract

Objective To investigate the influence of Fuzheng Xiaoji Decoction on tumor growth and immune function of tumor-bearing mice with lung cancer.
Methods A total of 30 specific pathogen free (SPF) C57BL/6 male mice were selected, of which 6 normal mice were included in control group, and the other 24 tumor-bearing model mice with lung cancer by subcutaneous injection were randomly divided into model group (treated with the same dose of normal saline), low dose group (treated with 125 mg/kg Fuzheng Xiaoji Decoction), medium dose group (treated with 250 mg/kg Fuzheng Xiaoji Decoction) and high dose group (treated with 500 mg/kg Fuzheng Xiaoji Decoction), with 6 mice in each group. The tumor volume was observed and the growth curve was drawn. Tumor weight was recorded and tumor inhibition rate was calculated. Thymus index and spleen index were recorded. Lymphocyte transformation and killing activity of specific cytotoxic T lymphocyte (CTL) were detected. The numbers of CD4⁺ T cells and CD8⁺ T cells in peripheral blood were detected by flow cytometry. Levels of serumtumor necrosis factor-α (TNF-α) and interleukin-2 (IL-2) in mice were detected by enzyme-linked immunosorbent assay.
Results On the 20th, 24th and 28th day after administration, the tumor volumes of mice in different doses of Fuzheng Xiaoji Decoction groups were significantly smaller than those in the model group, and the tumor volume of the high dose group was smaller than that of the low dose group and the medium dose group (P < 0.05). The tumor weights of mice in different doses of Fuzheng Xiaoji Decoction groups were significantly lower than that in the model group, while the tumor inhibition rates were significantly higher than that in the model group(P < 0.05). Compared with the control group, the spleen index, thymus index, the number of CD4⁺ T cells, value of CD4⁺/CD8⁺, lymphocyte transformation, killing activity of CTL as well as serum TNF-α and IL-2 in the model group reduced significantly, while the number of CD8⁺ T cells increased significantly (P < 0.05). Compared with the model group, the spleen index, thymus index, the number of CD4⁺ T cells, value of CD4⁺/CD8⁺, lymphocyte transformation, killing activity of CTL as well as serum TNF-α and IL-2 in the middle dose and high dose groups increased significantly, while the number of CD8⁺ T cells decreased significantly (P < 0.05).
Conclusion Fuzheng Xiaoji Decoction can inhibit tumor growth and improve immune function of tumor-bearing mice, which is related to its promoting effect on CD8⁺ T cells to secrete IL-2 and TNF-α.
- Fuzheng Xiaoji Decoction,
- non-small cell lung cancer,
- mice,
- tumor,
- growth,
- immunity

FullText(HTML)

References (24)

References

[1]	周健坤. 晚期非小细胞肺癌靶向治疗研究进展[J]. 临床肺科杂志, 2021, 26(7): 1104-1109. doi: 10.3969/j.issn.1009-6663.2021.07.030
[2]	PULENDRAN B, DAVIS M M. The science and medicine of human immunology[J]. Science, 2020, 369(6511): 4014. doi: 10.1126/science.aay4014
[3]	童向斌, 马君, 胡期伟. 替吉奥联合扶正消积汤治疗晚期胰腺癌的临床疗效观察[J]. 浙江医学, 2021, 43(6): 669-671. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202106025.htm
[4]	宋庆, 张春盈, 冯艳亮. 扶正消积汤联合化疗治疗晚期结肠癌疗效观察及对肿瘤标记物、免疫功能指标的影响[J]. 福建中医药, 2019, 50(3): 13-14, 22. https://www.cnki.com.cn/Article/CJFDTOTAL-FJZY201903004.htm
[5]	李秀芹, 张明奎, 张斌斌, 等. FOLFOX4化疗联合自拟中药扶正消积汤治疗中晚期结肠癌患者的临床效果及安全性[J]. 现代中西医结合杂志, 2019, 28(6): 635-637. doi: 10.3969/j.issn.1008-8849.2019.06.018
[6]	DE ANGELIS I, RICCERI L, VITALE A. The 3R principle: 60 years taken well. Preface[J]. Ann Ist Super Sanita, 2019, 55(4): 398-399.
[7]	赵星雨, 李囿松. 生脉饮联合顺铂对气阴两虚型肺癌荷瘤小鼠抗肿瘤作用的研究[J]. 中医肿瘤学杂志, 2021, 3(3): 47-51. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYZL202103009.htm
[8]	黄向春, 曹国立. 曹国立教授辨治肺癌经验撷粹[J]. 湖南中医药大学学报, 2021, 41(4): 603-607. doi: 10.3969/j.issn.1674-070X.2021.04.018
[9]	龚时夏, 薛青, 耿雨晴, 等. 赵景芳治疗中晚期肺癌经验[J]. 山西中医, 2021, 37(6): 4-5. doi: 10.3969/j.issn.1000-7156.2021.06.003
[10]	石潇, 周慧灵, 刘铸, 等. 林洪生以软坚散结法治疗肺癌的临床经验[J]. 世界中医药, 2021, 16(9): 1482-1484. doi: 10.3969/j.issn.1673-7202.2021.09.025
[11]	王静. 扶正消积汤联合卡培他滨、奥沙利铂治疗晚期结肠癌临床观察[J]. 长治医学院学报, 2019, 33(6): 467-470. doi: 10.3969/j.issn.1006-0588.2019.06.017
[12]	谭武宾, 李铁求, 李嘉辉, 等. 通过网络药理学研究白术治疗前列腺癌的作用机制[J]. 中国中西医结合外科杂志, 2021, 27(3): 425-432. doi: 10.3969/j.issn.1007-6948.2021.03.011
[13]	于超, 尹先哲, 关红梅. 黄芪注射液对肺癌细胞凋亡及PI3K/AKT信号通路的影响[J]. 新中医, 2021, 53(12): 145-148. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202112039.htm
[14]	孙沐炎. 五苓散临证思考[J]. 新中医, 2021, 53(11): 12-14. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202111003.htm
[15]	倪跃, 叶仲昊, 赵胜男, 等. 祛湿药对肠道菌群的影响[J]. 中医学报, 2021, 36(5): 983-988. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZK202105019.htm
[16]	李叶, 孟伟明, 赵雪梅. 鸡内金提取物通过调节肺泡巨噬细胞自噬水平减轻尘肺大鼠肺间质纤维化的机制[J]. 临床和实验医学杂志, 2021, 20(8): 792-796. doi: 10.3969/j.issn.1671-4695.2021.08.003
[17]	张静, 刘畅. 中西医结合治疗晚期结肠癌的临床疗效[J]. 湖南中医药大学学报, 2017, 37(5): 548-551. doi: 10.3969/j.issn.1674-070X.2017.05.023
[18]	曹丹. 扶正消积汤对中晚期结肠癌免疫功能的改善作用研究[J]. 湖北科技学院学报: 医学版, 2016, 30(6): 516-518. https://www.cnki.com.cn/Article/CJFDTOTAL-XNYB201606026.htm
[19]	李慧, 冷静, 秦毅. 扶正消积汤含药血清通过下调miR-184促进人肺腺癌SPC-A1细胞凋亡的影响[J]. 世界中西医结合杂志, 2021, 16(2): 277-280. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX202102020.htm
[20]	刘文立, 莫海云. 白及多糖通过调节免疫作用抑制结肠癌CT26荷瘤小鼠肿瘤生长[J]. 中国免疫学杂志, 2021, 37(8): 941-945. doi: 10.3969/j.issn.1000-484X.2021.08.010
[21]	刘艳玲, 袁娟, 郭敏, 等. 基于TLR4/MyD88/NF-κB信号通路探讨黄芪多糖对肺癌小鼠免疫功能的影响及对Th1/Th2的调节作用[J]. 中国免疫学杂志, 2021, 37(6): 676-682. doi: 10.3969/j.issn.1000-484X.2021.06.008
[22]	ZHU X, ZHU J. CD4 T Helper Cell Subsets and Related Human Immunological Disorders[J]. Int J Mol Sci, 2020, 21(21): 8011. doi: 10.3390/ijms21218011
[23]	MEIKLE C K, MEISLER A J, BIRD C M, et al. Platelet-T cell aggregates in lung cancer patients: Implications for thrombosis[J]. PLoS One, 2020, 15(8): e0236966. doi: 10.1371/journal.pone.0236966
[24]	JIESHENG L, HANNAH Y, ZEMIN Z, et al. Landscape of transcript isoforms in single T cells infiltrating in non-small-cell lung cancer[J]. J Genet Genomics, 2020, 47(7): 373-388. doi: 10.1016/j.jgg.2020.06.006

[1]	LI Yang, JIANG Lifeng, SUN Xu, LIU Huaimin. Research progress of immune checkpoint inhibitors based biotherapeutics in epidermal growth factor receptor mutant of non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 142-148. DOI: 10.7619/jcmp.20214607
[2]	HU Jing. Study on the changes of immune cell function in children with Mycoplasmal pneumoniae pneumonia[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 60-62. DOI: 10.7619/jcmp.202022017
[3]	WANG Qian, SHEN Lijuan, GUAN Yunyan. Effect of immune-type enteral nutrition support on immune function of severe patients in ICU[J]. Journal of Clinical Medicine in Practice, 2017, (15): 71-73,77. DOI: 10.7619/jcmp.201715019
[4]	LI Shaoxing. Effect of different surgical treatment on immune function of patients with benign ovarian tumor[J]. Journal of Clinical Medicine in Practice, 2017, (5): 93-96. DOI: 10.7619/jcmp.201705026
[5]	ZHU Xuemei. Effect of diet nursing intervention on nutritional index and immune function of patients with gastric cancer after radical operation[J]. Journal of Clinical Medicine in Practice, 2016, (18): 73-75. DOI: 10.7619/jcmp.201618024
[6]	YANG Xianghong, LI Yanli, LUO Chunyu. Changes of immune function in children with mycoplasma pneumoniae pneumonia and its relationship with disease degrees and staging[J]. Journal of Clinical Medicine in Practice, 2016, (7): 113-116. DOI: 10.7619/jcmp.201607033
[7]	LI Xiuling. Effect of laparoscopic hysterectomy on ovarian function and immune function[J]. Journal of Clinical Medicine in Practice, 2016, (7): 93-95,108. DOI: 10.7619/jcmp.201607027
[8]	JIA Haiying. Effect of oral probiotics on treatment of neonates with hyperbilirubinemia and its influence on immune function[J]. Journal of Clinical Medicine in Practice, 2015, (7): 104-106. DOI: 10.7619/jcmp.201507030
[9]	SHI Xufeng, XU Fei. Efficacy of laparoscopic radical operation for gastric cancer and its influence on the immune function[J]. Journal of Clinical Medicine in Practice, 2014, (13): 133-134,137. DOI: 10.7619/jcmp.201413045
[10]	ZHANG Yumei, WANG Jiaxiao. Influence of ginsenoside Rg3 on proliferation of Lewis lung cancer cells in vitro and immune function of tumor-bearing mice[J]. Journal of Clinical Medicine in Practice, 2014, (1): 5-8. DOI: 10.7619/jcmp.201401002

Cited By

Cited by

Periodical cited type(2)

1.	代莉亚，王晓英，梁利杰. 1M3S护理管理模式对原发性肝癌手术患者手术结局、术后肠道微生态分布及免疫功能的影响. 国际护理学杂志. 2023(15): 2808-2811 .
2.	曲畅. 基于品管圈活动的三维质控护理对重症急性胰腺炎血液滤过患者生活质量及并发症的影响. 吉林医学. 2023(12): 3540-3543 .

Other cited types(0)

Get Citation

PDF

XML

Article views (346) PDF downloads (17) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Improvement research of Fuzheng Xiaoji Decoctionon tumor growth inhibition and immune function of mice model with lung cancer